unknown
Stage
About
GeneCentric develops liquid biopsy technologies that extract gene expression data from circulating tumor DNA to improve cancer genomic profiling and precision oncology.
Explore GeneCentric's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.